Gerards A - Search Results

1

Cyclosporin in rheumatoid arthritis: monitoring for adverse effects and clinically significant drug interactions.

Dijkmans B, Gerards A. Dijkmans B, et al. Among authors: gerards a. BioDrugs. 1998 Dec;10(6):437-45. doi: 10.2165/00063030-199810060-00002. BioDrugs. 1998. PMID: 18020613

2

Disease flares in rheumatoid arthritis are associated with joint damage progression and disability: 10-year results from the BeSt study.

Markusse IM, Dirven L, Gerards AH, van Groenendael JH, Ronday HK, Kerstens PJ, Lems WF, Huizinga TW, Allaart CF. Markusse IM, et al. Arthritis Res Ther. 2015 Aug 31;17(1):232. doi: 10.1186/s13075-015-0730-2. Arthritis Res Ther. 2015. PMID: 26321751 Free PMC article.

3

Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial.

Gerards AH, Landewé RB, Prins AP, Bruyn GA, Goei Thé HS, Laan RF, Dijkmans BA. Gerards AH, et al. Ann Rheum Dis. 2003 Apr;62(4):291-6. doi: 10.1136/ard.62.4.291. Ann Rheum Dis. 2003. PMID: 12634224 Free PMC article. Clinical Trial.

4

Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritis.

Gerards AH, de Lathouder S, de Groot ER, Dijkmans BA, Aarden LA. Gerards AH, et al. Rheumatology (Oxford). 2003 Oct;42(10):1189-96. doi: 10.1093/rheumatology/keg323. Epub 2003 May 30. Rheumatology (Oxford). 2003. PMID: 12777636

5

Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis.

Klarenbeek NB, Koevoets R, van der Heijde DM, Gerards AH, Ten Wolde S, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF. Klarenbeek NB, et al. Among authors: gerards ah. Ann Rheum Dis. 2011 Oct;70(10):1815-21. doi: 10.1136/ard.2010.149260. Epub 2011 Aug 3. Ann Rheum Dis. 2011. PMID: 21813548 Clinical Trial.

6

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial.

Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, Zwinderman AH, Ronday HK, Han KH, Westedt ML, Gerards AH, van Groenendael JH, Lems WF, van Krugten MV, Breedveld FC, Dijkmans BA. Goekoop-Ruiterman YP, et al. Among authors: gerards ah. Arthritis Rheum. 2008 Feb;58(2 Suppl):S126-35. doi: 10.1002/art.23364. Arthritis Rheum. 2008. PMID: 18240203 Clinical Trial.

7

Rapid radiological progression in the first year of early rheumatoid arthritis is predictive of disability and joint damage progression during 8 years of follow-up.

van den Broek M, Dirven L, de Vries-Bouwstra JK, Dehpoor AJ, Goekoop-Ruiterman YP, Gerards AH, Kerstens PJ, Huizinga TW, Lems W, Allaart CF. van den Broek M, et al. Among authors: gerards ah. Ann Rheum Dis. 2012 Sep;71(9):1530-3. doi: 10.1136/annrheumdis-2011-201212. Epub 2012 Apr 24. Ann Rheum Dis. 2012. PMID: 22532630

8

Accelerated hand bone mineral density loss is associated with progressive joint damage in hands and feet in recent-onset rheumatoid arthritis.

Güler-Yüksel M, Klarenbeek NB, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, van der Kooij SM, Gerards AH, Ronday HK, Huizinga TW, Dijkmans BA, Allaart CF, Lems WF. Güler-Yüksel M, et al. Among authors: gerards ah. Arthritis Res Ther. 2010;12(3):R96. doi: 10.1186/ar3025. Epub 2010 May 20. Arthritis Res Ther. 2010. PMID: 20482894 Free PMC article. Clinical Trial.

9

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.

Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, Zwinderman AH, Ronday HK, Han KH, Westedt ML, Gerards AH, van Groenendael JH, Lems WF, van Krugten MV, Breedveld FC, Dijkmans BA. Goekoop-Ruiterman YP, et al. Among authors: gerards ah. Arthritis Rheum. 2005 Nov;52(11):3381-90. doi: 10.1002/art.21405. Arthritis Rheum. 2005. PMID: 16258899 Clinical Trial.

10

Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial.

de Jong PH, Hazes JM, Barendregt PJ, Huisman M, van Zeben D, van der Lubbe PA, Gerards AH, de Jager MH, de Sonnaville PB, Grillet BA, Luime JJ, Weel AE. de Jong PH, et al. Among authors: gerards ah. Ann Rheum Dis. 2013 Jan;72(1):72-8. doi: 10.1136/annrheumdis-2011-201162. Epub 2012 Jun 7. Ann Rheum Dis. 2013. PMID: 22679301 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results